Company Monitoring Page for Vivus

latest headlines for company on cafepharma

Vivus Could Surge On Qnexa Approval
Motley Fool
Sat, 04/14/12 - 12:25 pm
Tags:
Vivus, Qnexa, obesity
Handicapping The Obesity Race
Seeking Alpha
Wed, 04/11/12 - 10:59 am
Tags:
obesity, Vivus, Arena Pharmaceuticals, Orexigen
Vivus Tumbles On Extended FDA Review
Barron's
Tue, 04/10/12 - 11:08 am
Tags:
FDA, Vivus, Qnexa, obesity
FDA will take 3 more months to review Vivus drug
Yahoo/AP
Mon, 04/9/12 - 05:43 pm
Tags:
Vivus, FDA, Qnexa, obesity
Vivus: Ready To Gain From Qnexa
Seeking Alpha
Mon, 04/9/12 - 11:57 am
Tags:
Vivus, Qnexa, obesity, JNJ, Novartis, Pfizer, Teva Pharmaceuticals
Vivus' ED Drug Will Make Investors Money
Motley Fool
Thu, 04/5/12 - 09:11 pm
Tags:
erectile dysfunction, Vivus, Avanafil
Focus On Upcoming FDA Drug Approval And Advisory Dates
Seeking Alpha
Wed, 04/4/12 - 11:18 am
Tags:
FDA, XenoPort, Horizant, lorcaserin, Arena Pharmaceuticals, Qnexa, Vivus, Protalix BioTherapeutics, GSK, taliglucerase
For Biotech Takeovers, Timing is Key
TheStreet.com
Wed, 04/4/12 - 08:44 am
Tags:
M&A, biotech, Vivus, Arena Pharmaceuticals, Discovery Labs
3 Anti-Obesity Drug Companies Poised To Grow
Seeking Alpha
Tue, 04/3/12 - 08:59 am
Tags:
obesity, Vivus, Orexigen, lorcaserin, Arena Pharmaceuticals, Contrave, Qnexa
Another Option Strategy For Vivus
Seeking Alpha
Tue, 04/3/12 - 08:58 am
Tags:
Vivus, options
Sector Snap: Obesity drug companies
Yahoo/AP
Sat, 03/31/12 - 11:49 am
Tags:
Orexigen, Vivus, lorcaserin, Qnexa, Arena Pharmaceuticals, Contrave, obesity
Vivus, Arena Unlikely to Be Affected by FDA Obesity Panel
Bloomberg
Fri, 03/30/12 - 12:00 pm
Tags:
Arena, Vivus, FDA, obesity, advisory panels, Orexigen
Will Obesity Drugs Do Better in Europe?
Motley Fool
Thu, 03/29/12 - 12:16 pm
Tags:
obsesity, Arena, Vivus, Orexigen, lorcaserin, Contrave, Qnexa
Large Market Opportunity Emerges For Oculus Technology
Seeking Alpha
Wed, 03/28/12 - 10:19 am
Tags:
Oculus, GSK, JNJ, Novartis, Sanofi, Vivus
Obesity Drugs May Need Heart Risk Studies Before Approval
Bloomberg
Mon, 03/26/12 - 12:22 pm
Tags:
obesity, Vivus, Arena Pharmaceuticals, Orexigen, Qnexa
VIVUS Announces Acceptance of Avanafil Application in Europe
Yahoo
Mon, 03/26/12 - 12:20 pm
Tags:
Vivus, Avanafil, Europe, erectile dysfunction
20 Biotech Stocks Being Bought Up By Hedge Funds
Seeking Alpha
Sun, 03/25/12 - 11:38 am
Tags:
Achillion, Amylin, Ariad Pharmaceuticals, Aveo Pharmaceutical, Cell Therapeutics, EXACT Sciences, Idenix, Exelixis, Halozyme, Lexicon Pharmaceuticals, Nektar, Momenta, ONYX Pharmaceuticals, Optimer Pharmaceuticals, PDL Biopharma, Questcor Pharmaceuticals, Santarus, Spectrum Pharmaceuticals, Regeneron, Vivus
A Picture is Worth a Thousand Words: The Difference Between "Yes" and "No" During an FDA Advisory Committee
Elsevier Business
Fri, 03/9/12 - 10:49 am
Tags:
FDA, advisory panels, Xgeva, Amgen, Vivus, Qnexa
9 Biotech Stocks With Significant Liquidity Growth
Seeking Alpha
Sat, 03/3/12 - 11:12 am
Tags:
Corcept Therapeutics, Hi Tech Pharmacal, Questcor Pharmaceuticals, Myriad Genetics, QLT Inc, Valeant Pharmaceuticals, Rigel Pharmaceuticals, Techne, Vivus
Biotech Stock Mailbag: Cyclacel Fallout, the Skinny on Vivus, Celldex's Crash
TheStreet.com
Fri, 03/2/12 - 10:10 am
Tags:
Cyclacel, Vivus, Celldex, Astex, Discovery Labs, Exelixis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.